Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Peter AltmanPresident and CEO | BioCardiaBCDA | Open-market buy | 09/29 | 09/30 | 1,000 sh | $1.03 | $1,030 | +0.3% |
Peter AltmanPresident and CEO | BioCardiaBCDA | Open-market buy | 09/23 | 09/23 | 1,900 sh | $1.05 | $1,995 | +0.5% |
BioCardiaBCDA | Open-market buy | 06/22–06/23 | 06/24 | 109,200 sh2 trades | $0.95avg. | $103,584 | +191.1% | |
BioCardiaBCDA | Open-market buy | 06/17–06/18 | 06/22 | 2,300 sh2 trades | $0.89avg. | $2,043 | +0.8% | |
Peter AltmanPresident and CEO | BioCardiaBCDA | Open-market buy | 06/09 | 06/09 | 5,000 sh | $0.85 | $4,250 | +1.7% |
BioCardiaBCDA | Open-market buy | 05/19–05/20 | 05/21 | 1,700 sh2 trades | $0.92avg. | $1,570 | +0.6% | |
Peter AltmanPresident and CEO | BioCardiaBCDA | Open-market buy | 05/18 | 05/18 | 5,700 sh | $0.92 | $5,244 | +2.0% |
Peter AltmanPresident and CEO | BioCardiaBCDA | Open-market buy | 05/15 | 05/15 | 5,100 sh | $1.02 | $5,202 | +1.8% |
Peter AltmanPresident and CEO | BioCardiaBCDA | Open-market buy | 04/29 | 04/29 | 5,000 sh | $1.11 | $5,550 | +1.8% |
BioCardiaBCDA | Open-market buy | 04/20–04/21 | 04/22 | 1,000 sh2 trades | $1.23avg. | $1,230 | +0.4% | |
BioCardiaBCDA | Open-market buy | 03/24–03/25 | 03/26 | 900 sh2 trades | $1.23avg. | $1,110 | +0.3% | |
Peter AltmanPresident and CEO | BioCardiaBCDA | Open-market buy | 02/04 | 02/04 | 5,000 sh | $1.13 | $5,650 | +1.9% |
BioCardiaBCDA | Open-market buy | 01/20–01/21 | 01/21 | 900 sh2 trades | $1.33avg. | $1,194 | +0.3% | |
BioCardiaBCDA | Open-market buy | 25/12/16–25/12/17 | 25/12/17 | 1,100 sh2 trades | $1.31avg. | $1,444 | +0.4% | |
Simon H. StertzerDirector | BioCardiaBCDA | Open-market buy | 25/09/19 | 25/09/23 | 398,400 sh | $1.25 | $498,000 | +206.8% |
Peter AltmanPresident and CEO | BioCardiaBCDA | Open-market buy | 25/09/19 | 25/09/23 | 48,000 sh | $1.25 | $60,000 | +28.4% |
Andrew Scott BlankDirector | BioCardiaBCDA | Open-market buy | 25/09/19 | 25/09/23 | 288,000 sh | $1.25 | $360,000 | +83.2% |
Peter AltmanPresident and CEO | BioCardiaBCDA | Open-market buy | 25/08/22 | 25/08/25 | 700 sh | $1.83 | $1,281 | +0.4% |
Peter AltmanPresident and CEO | BioCardiaBCDA | Open-market buy | 25/08/13 | 25/08/13 | 100 sh | $1.83 | $183 | +0.1% |
Peter AltmanPresident and CEO | BioCardiaBCDA | Open-market buy | 25/08/12 | 25/08/12 | 400 sh | $1.75 | $700 | +0.2% |